| Company Name: | A Schulman, Inc. | | Ticker Symbol: | SHLM | | | WWW Address: | www.aschulman.com |
| CEO: | Mr. Joseph M. Gingo | | No. of Employees: | 3,300 |
| Common Issue Type: | CS | | Business Description: | A Schulman, Inc. supplies plastic compounds, resins & engineered plastics. It offers products such as Polybatch, Schulamid, Fermion, Clarix & Agriplas & also provides polypropylene, rotational molding, injection molding & extrusion applications.
|
| | | Industry Information: | CHEMICALS - Chemicals - Major Diversified [more like this] |
| | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 28.8 |  0.12 | 25.0 | 31.46 | 28.68 | 28.91 | 28.48 | 104814 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 847.4 | 29.4 | 1.25 | 1.72 | 0.72 | 16.5 | 2.7 | 33.40 - 17.75 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 28.80 | $ | | PE Ratio - LTM | 16.5 | |
| Market Capitalisation | 847.4 | mil |
| Latest Shares Outstanding | 29.4 | mil |
| Earnings pS (EPS) | 1.72 | $ |
| Dividend pS (DPS) | 0.72 | ¢ |
| Dividend Yield | 2.7 | % |
| Dividend Payout Ratio | 42 | % |
| Revenue per Employee | 679,598 | $ |
| Effective Tax Rate | 21.1 | % |
| Float | 28.4 | mil |
| Float as % of Shares Outstanding | 96.9 | % |
| Foreign Sales | 1,748 | mil |
| Domestic Sales | 358 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 9.20 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 14.7 | % |
| EBITDA Margin | 5.6 | % |
| Pre-Tax Profit Margin | 2.8 | % |
| Assets Turnover | 1.7 | % |
| Return on Assets (ROA) | 3.3 | % |
| Return on Equity (ROE) | 7.9 | % |
| Return on Capital Invested (ROCI) | 5.8 | % |
| Current Ratio | 1.9 | |
| Leverage Ratio (Assets/Equity) | 2.4 | |
| Interest Cover | 7.5 | |
| Total Debt/Equity (Gearing Ratio) | 0.43 | |
| LT Debt/Total Capital | 27.0 | % |
| Working Capital pS | 11.92 | $ |
| Cash pS | 2.71 | $ |
| Book-Value pS | 17.92 | $ |
| Tangible Book-Value pS | 9.79 | $ |
| Cash Flow pS | 2.79 | $ |
| Free Cash Flow pS | -0.33 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.61 | |
| Price/Tangible Book Ratio | 2.94 | |
| Price/Cash Flow | 10.3 | |
| Price/Free Cash Flow | -88.0 | |
| P/E as % of Industry Group | 95.0 | % |
| P/E as % of Sector Segment | 73.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 04/08/2013 |
| Dividend Ex-Date | 04/16/2013 |
| Dividend Record Date | 04/18/2013 |
| Dividend Pay Date | 04/30/2013 |
| Dividend Amount | 195 |
| Type of Payment | Cash Payment |
| Dividend Rate | 0.78 |
| Current Dividend Yield | 2.7 |
| 5-Y Average Dividend Yield | 3.1 |
| Payout Ratio | 42.0 |
| 5-Y Average Payout Ratio | 43.0 |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -2.1 | 99 | 1,910 | 5,421 |
| 4 Weeks | 29.95 | 25.32 | 25.26 | 14.0 | 109 | 2,021 | 40,421 |
| 13 Weeks | 32.90 | 24.61 | 31.80 | -9.4 | 83 | 1,862 | 119,166 |
| 26 Weeks | 33.40 | 24.61 | 25.36 | 13.6 | 97 | 1,703 | 212,828 |
| 52 Weeks | 33.40 | 17.75 | 21.79 | 32.2 | 106 | 1,566 | 389,887 |
| YTD | 33.40 | 24.61 | - | -0.5 | 86 | 1,766 | 176,554 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 29.11 | 29.00 | 28.39 | 28.95 | 27.58 | 1.25 | 1.67 |
| | | | GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 4.54 | 16.9 | 13.85 |
| Income | 0.00 | 0.0 | 31.55 |
| Dividend | 4.61 | 76.1 | 7.46 |
| Capital Spending | 23.76 | NA | 36.68 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 14.25 | NA | 10.78 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 4.9 | 5.3 | -3.9 |
| Earnings % | 6.7 | 32.5 | 24.9 |
| EPS % | 2.6 | 29.0 | 30.3 |
| EPS $ | 0.02 | 0.09 | 0.40 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 28.57 |
| Current Ratio | 1.9 |
| Quick Ratio (Acid Test) | 1.2 |
| Liquidity Ratio (Cash) | 0.34 |
| Receivables Turnover | 6.5 |
| Average Collection Period | 55 |
| Working Capital/Equity | 68.0 |
| Working Capital pS | 11.64 |
| Cash-Flow pS | 3.10 |
| Free Cash-Flow pS | -0.69 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.17 |
| Financial Leverage Ratio (Assets/Equity) | 2.4 |
| Debt Ratio | 58.0 |
| Total Debt/Equity (Gearing Ratio) | 0.42 |
| LT Debt/Equity | 0.35 |
| LT Debt/Capital Invested | 48.1 |
| LT Debt/Total Liabilities | 25.2 |
| Interest Cover | 8.9 |
| Interest/Capital Invested | 1.01 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 8.03 |
| Tobin's Q Ratio | 0.71 |
| Current P/E Ratio - LTM | 16.50 |
| Enterprise Value (EV)/EBITDA | 11.44 |
| Enterprise Value (EV)/Free Cash Flow | -138.99 |
| Dividend Yield | 2.7 |
| Price/Tangible Book Ratio - LTM | 2.94 |
| Price/Book Ratio - LTM | 1.61 |
| Price/Cash Flow Ratio | 10.3 |
| Price/Free Cash Flow Ratio - LTM | -88.0 |
| Price/Sales Ratio | 0.39 |
| P/E Ratio (1 month ago) - LTM | 15.1 |
| P/E Ratio (26 weeks ago) - LTM | 14.7 |
| P/E Ratio (52 weeks ago) - LTM | 14.6 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 95.0 |
| P/E as % of Sector Segment | 73.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 12.8 |
| PER SHARE FIGURES |
| LT Debt pS | 5.95 |
| Current Liabilities pS | 12.53 |
| Tangible Book Value pS - LTM | 9.79 |
| Book Value pS - LTM | 17.92 |
| Capital Invested pS | 22.97 |
| Cash pS - LTM | 2.71 |
| Cash Flow pS - LTM | 2.79 |
| Free Cash Flow pS - LTM | -0.33 |
| Earnings pS (EPS) | 1.72 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -0.97 |
| Free Cash Flow Margin 5YEAR AVG | 1.56 |
| Net Profit Margin | 2.5 |
| Net Profit Margin - 5YEAR AVRG. | 1.7 |
| Equity Productivity | 4.20 |
| Return on Equity (ROE) | 10.4 |
| Return on Equity (ROE) - 5YEAR AVRG. | 6.6 |
| Capital Invested Productivity | 3.12 |
| Return on Capital Invested (ROCI) | 7.7 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 5.1 |
| Assets Productivity | 1.70 |
| Return on Assets (ROA) | 4.4 |
| Return on Assets (ROA) - 5YEAR AVRG. | 2.9 |
| Gross Profit Margin | 14.7 |
| Gross Profit Margin - 5YEAR AVRG. | 14.9 |
| EBITDA Margin - LTM | 5.6 |
| EBIT Margin - LTM | 3.1 |
| Pre-Tax Profit Margin | 3.1 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 2.4 |
| Effective Tax Rate | 21.1 |
| Effective Tax Rate - 5YEAR AVRG. | 24.9 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 103 |
| Revenue per Employee | 679,598 |
| Net Income per Employee | 16,790 |
| Average Collection Period | 52 |
| Receivables Turnover | 6.5 |
| Day's Inventory Turnover Ratio | 51 |
| Inventory Turnover | 7.0 |
| Inventory/Sales | 11.7 |
| Accounts Payble/Sales | 11.77 |
| Assets/Revenue | 0.59 |
| Net Working Capital Turnover | 6.18 |
| Fixed Assets Turnover | 4.34 |
| Total Assets Turnover | 1.7 |
| Revenue per $ Cash | 16.99 |
| Revenue per $ Plant | 9.33 |
| Revenue per $ Common Equity | 4.20 |
| Revenue per $ Capital Invested | 3.12 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 9.1 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 9.9 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
| | |  |  | |
| |
